Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 12, 2022

BUY
$247.06 - $1507.4 $8,400 - $51,251
34 Added 3.52%
999 $258,000
Q2 2022

Jul 11, 2022

BUY
$237.11 - $299.66 $53,112 - $67,123
224 Added 30.23%
965 $249,000
Q1 2022

Apr 22, 2022

BUY
$257.27 - $315.76 $190,637 - $233,978
741 New
741 $202,000
Q4 2021

Jan 26, 2022

SELL
$292.08 - $329.01 $209,421 - $235,900
-717 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$272.21 - $332.43 $816 - $997
-3 Reduced 0.42%
717 $216,000
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $162,057 - $195,616
720 New
720 $222,000
Q1 2021

May 25, 2021

SELL
$212.38 - $245.9 $243,175 - $281,555
-1,145 Closed
0 $0
Q4 2020

Jan 27, 2021

SELL
$212.5 - $245.46 $25,925 - $29,946
-122 Reduced 9.63%
1,145 $270,000
Q3 2020

Oct 23, 2020

SELL
$177.16 - $215.33 $8,858 - $10,766
-50 Reduced 3.8%
1,267 $288,000
Q2 2020

Jul 21, 2020

BUY
$128.7 - $176.83 $169,497 - $232,885
1,317 New
1,317 $251,000
Q1 2020

Apr 09, 2020

SELL
$121.39 - $169.05 $179,899 - $250,532
-1,482 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$133.47 - $153.48 $1,601 - $1,841
12 Added 0.82%
1,482 $238,000
Q3 2019

Oct 22, 2019

SELL
$135.4 - $146.47 $4,739 - $5,126
-35 Reduced 2.33%
1,470 $204,000
Q2 2019

Aug 05, 2019

SELL
$124.88 - $143.73 $6,868 - $7,905
-55 Reduced 3.53%
1,505 $211,000
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $65,503 - $88,766
-671 Reduced 30.08%
1,560 $204,000
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $218,928 - $242,955
2,231 New
2,231 $242,000
Q1 2018

Jun 01, 2018

SELL
$92.16 - $103.8 $533,422 - $600,794
-5,788 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $493,484 - $547,660
5,788
5,788 $537,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.